* To use proceeds to pay dividend
* Expected to trade on Nasdaq as "EPOC"
July 16 Clinical information provider Epocrates
Inc filed with U.S. regulators on Friday to raise up to $75
million through an initial public offering of common stock.
The company provides mobile drug reference tools to
healthcare professionals and interactive services to the
healthcare industry, according to a regulatory filing with the
U.S. Securities and Exchange Commission.
The company posted revenue of $93.7 million for 2009, up 12
percent from a year earlier.
It posted net profit of $7.7 million, up 3 percent from the
The company said it would use proceeds from the offering to
pay preferred stock dividend of about $27.2 million and for
general corporate purposes.
It did not say how many shares it plans to sell or provide
an expected price range.
The underwriters to the offering are co-led by J.P.Morgan
and Piper Jaffray.
The stock is expected to trade on Nasdaq under the symbol
(Reporting by Debasmita Ghosh in Bangalore; Editing by Vyas